Skip to main content
. 2021 Aug 17;22(16):8841. doi: 10.3390/ijms22168841

Figure 9.

Figure 9

Schematic representation of the inhibition of HepG2 cell proliferation and metastasis by SCU. SCU inhibits proliferation and metastasis through suppression of PI3K/Akt/NF-κB signaling pathway by inducing PTEN and regulating EMT markers and migration-related proteins (E-cadherin, N-cadherin, Snail, TIMP2, MMP-2, and MMP-9) in HepG2 cells.